Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A
about
B-Cell Epitopes in GroEL of Francisella tularensisThe route less taken: pulmonary models of enteric Gram-negative infectionImmunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS)TLR-dependent control of Francisella tularensis infection and host inflammatory responsesCurrent status of vaccine development for tularemia preparedness.Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain.Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strainIdentification of an essential Francisella tularensis subsp. tularensis virulence factor.A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge.Interrelationship between dendritic cell trafficking and Francisella tularensis dissemination following airway infection.The Fischer 344 rat reflects human susceptibility to francisella pulmonary challenge and provides a new platform for virulence and protection studiesIdentification of early interactions between Francisella and the host.Bronchus-associated lymphoid tissue (BALT) and survival in a vaccine mouse model of tularemia.Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice.Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy.The yersiniabactin transport system is critical for the pathogenesis of bubonic and pneumonic plague.Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensisLong lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs.A Francisella tularensis live vaccine strain that improves stimulation of antigen-presenting cells does not enhance vaccine efficacyTularemia vaccines: recent developments and remaining hurdles.Low dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination.Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.Mucosal immunization with live attenuated Francisella novicida U112ΔiglB protects against pulmonary F. tularensis SCHU S4 in the Fischer 344 rat modelIntranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in miceSuccessful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.The francisella tularensis proteome and its recognition by antibodies.Characterization of monoclonal antibodies to terminal and internal O-antigen epitopes of Francisella tularensis lipopolysaccharide.Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge.Mouse model of oral infection with virulent type A Francisella tularensis.Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine.Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain.Infection of mice with Francisella as an immunological modelGeneration and characterization of hybridoma antibodies for immunotherapy of tularemia.Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia.Airway CD8(+) T cells induced by pulmonary DNA immunization mediate protective anti-viral immunity.Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis.
P2860
Q27684471-F937D6E6-5CB2-493F-85CB-1F87013F08A1Q27691303-76099F0A-69A1-4111-B696-F9513A5DD452Q28748210-21BFB55B-B06D-44A6-82D8-8DB560B30FC8Q28750216-8558DD39-B50E-405F-833F-E985E7396D05Q30223106-B2D61860-637A-4526-9234-D00F3BDE3FB7Q30409782-B09C5F30-A9BA-4A51-9F2C-EF72CD0244AEQ30411506-1D94B505-A956-4481-939F-2144A74348F8Q30439303-215AAF2A-A623-4452-938A-E90565D67A7CQ33346284-CE1B991D-4206-47E5-A8FB-AA86F2D38952Q33386012-BCCF6844-4E7F-4DD3-99B2-B400AFC5FF14Q33550808-06FB2732-36F8-4817-9810-6C64203CA333Q33602941-9BDF20F4-4277-4D22-B6E4-802CC3E02ED9Q33618911-DD78FBA7-1235-47E3-AB95-5EB7C2553431Q33627084-01AF8B82-2456-4986-8AF5-87D3644AF733Q33653480-5198C4C6-D66D-4631-AA2C-0674EBF9331CQ33725674-71837922-8865-4B37-BDF9-06F446B03E7FQ33826085-FEDA21D6-14A7-400C-9F6E-1A3063112C6FQ33886324-A5CE63E1-A06C-4978-8ADC-E0E55854FF1BQ34126301-E8DF24CC-4121-4D97-95FC-C278C653B86AQ34166276-2A395E38-BFDA-4309-B3F9-419901BC1E7AQ34180914-B1E0140B-801C-45A9-8A00-FD9F8A465BF0Q34291236-84CAC829-6A70-46CA-8997-291B3B807CBAQ34423341-38DC4299-306B-41C9-8B8D-F2EE03C398E6Q34464553-1C61E90B-67A7-48A3-A154-CE23B6731172Q34492667-0972D72D-177D-43BE-94B1-687BBFE05438Q34552307-61A9C19C-289E-4606-8873-077FEB9736BAQ34784967-48B593BB-A113-4038-84CB-04E187FD46EEQ35029271-98F7B452-E78D-4878-907C-DA62FC24C44CQ35057751-FB9CCDF4-A30A-4321-A14C-10BFE7695DCBQ35073798-5AFF8882-A4FB-4786-ABAF-608582866D35Q35783736-30BD295D-84D4-40A1-A58D-D290CBEC4132Q35784151-E9233B46-853F-4C6B-8C1D-0A833F4D3FC4Q35808608-A93A09AA-D0E6-4ADA-B0E7-702E8F4BEEA7Q35910851-4AC550F4-1F7E-4C22-B1CA-94E4E4B739EFQ36018212-492FAF5A-C646-4634-99C4-2DFEB88E5325Q36119858-446CBD0B-E0E6-43A3-88A6-3C49E564BBC7Q36248755-5309D3DF-0C08-4E73-9108-D0235B05D0EFQ36421591-9C318577-E58A-4F0F-AC2B-FF2BF64B5EC2Q36499684-DA63F3E1-0E5C-4DFD-AB3F-C0E0D66DC61AQ36804275-261C47D1-A8C2-4D38-B07D-2B0DDA6A6FAB
P2860
Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Intranasal vaccination induces ...... rancisella tularensis biovar A
@ast
Intranasal vaccination induces ...... rancisella tularensis biovar A
@en
type
label
Intranasal vaccination induces ...... rancisella tularensis biovar A
@ast
Intranasal vaccination induces ...... rancisella tularensis biovar A
@en
prefLabel
Intranasal vaccination induces ...... rancisella tularensis biovar A
@ast
Intranasal vaccination induces ...... rancisella tularensis biovar A
@en
P2093
P2860
P1476
Intranasal vaccination induces ...... rancisella tularensis biovar A
@en
P2093
C Rick Lyons
Julie A Hutt
Kristin A Garrison
Lyudmila S Berliba
Terry H Wu
P2860
P304
P356
10.1128/IAI.73.5.2644-2654.2005
P407
P577
2005-05-01T00:00:00Z